The “Innovation Partnership for a Roadmap on Vaccines in Europe” (IPROVE) – financed under the EU 7th Framework Programme (FP7) – aimed to establish a clear vision of the priority innovations and technologies to boost research in the field of vaccine and vaccinology necessary to address infectious and non-infectious threats of importance to public health in Europe and beyond. Issues addressed included inter-alia R&D needs to develop vaccines for the ageing population, emerging threats from hospital infections, high incidence of chronic diseases, low levels of prevention awareness and readiness, as well as the suboptimal use of existing cost-effective vaccines across different age groups.
The roadmap finalised by March 2016 included strategic decisions on the priorities for future vaccine investment in innovation and technological development at the level of the EU as well as of individual Member States.
IPROVE Roadmap available
A strategic roadmap for the vaccines of tomorrow: a joint stakeholder reflection